Malignant mesothelioma with heterologous elements: Clinicopathological correlation of 27 cases and literature review

Department of Anatomical Pathology, Flinders University of South Australia, Adelaide, SA, Australia.
Modern Pathology (Impact Factor: 6.19). 07/2008; 21(9):1084-94. DOI: 10.1038/modpathol.2008.125
Source: PubMed


Only a small number of malignant mesotheliomas with heterologous elements have been described. There are currently no criteria for diagnosis and little data regarding prognosis. We suggest that the term heterologous mesothelioma should be reserved for tumours that show malignant heterologous elements, notably osteosarcomatous, chondrosarcomatous, or rhabdomyoblastic elements but have immunohistochemical and clinical characteristics of mesothelioma. We identified 27 such cases and characterized the clinical and pathological characteristics of these tumours. In our series, 89% originated in the pleura, and 11% from the peritoneal cavity. The median age at diagnosis was 68 years, ranging from 27 to 85 years. Of these cases, 93% occurred in males and 7% in women. Of the 27 mesothelioma cases 16 (59%) were sarcomatoid, 10 (37%) were biphasic, and one was reported as epithelioid; 40% (11 cases) showed osteosarcomatous elements only, 19% showed areas of rhabdomyosarcoma only, 19% contained areas of chondrosarcoma only, and 22% exhibited osteochondromatous elements. Immunohistochemical labelling for cytokeratins was present in the majority of cases. Exposure to asbestos was identified in all the 17 cases for which an exposure history was available (63%). Median survival was 6 months after diagnosis, similar to the survival seen in sarcomatoid mesotheliomas. The differential diagnosis includes primary and secondary pleural sarcomas, including osteosarcomas and chondrosarcomas. Immunohistochemical labelling for cytokeratins is helpful in the distinction, but lack of labelling for cytokeratins in a spindle cell/sarcomatoid tumour does not exclude the diagnosis of mesothelioma, irrespective of the presence of heterologous elements. We suggest that if the anatomical distribution conforms to that of mesothelioma, a diagnosis of heterologous mesothelioma should be made in preference to a diagnosis of primary pleural osteosarcoma or chondrosarcoma, regardless of cytokeratin positivity, as for conventional non-heterologous sarcomatoid mesothelioma.

Download full-text


Available from: Douglas W Henderson, Apr 07, 2015
25 Reads
  • Source
    • "Author No. of sarcomatous-type malignant peritoneal mesothelioma Our case 2010 1 Klebe et al. 18 2010 7 Griniatsos et al. 24 2009 1 Baratti et al. 25 2009 1 Kusama et al. 26 2009 1 Klebe et al. 27 2008 2 Hesdorffer et al. 28 2008 4 Zhang and Hao 29 2003 11 Feldman et al. 19 2003 4 Deraco et al. 30 2003 1 Sebbag et al. 31 2000 2 Neumann et al. 32 1999 1 Ros et al. 33 1991 2 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Sarcomatous malignant peritoneal mesothelioma developing in the abdominal cavity is very rare, and little is known about its behavior. A 72-year-old woman was referred to our hospital with anemia and weight loss. Tumor marker levels were within normal limits. Abdominal computed tomography showed an 11¥7 cm tumor in the pelvis, with possible invasion of the large bowel. Colonoscopy revealed a tumor protruding into the cecal lumen with an ulceration of the cecal wall. Although malignancy was suspected, the histological type was not identified in the biopsy specimens. Right hemicolectomy and ileocolic anastomosis were performed as a treatment. A postoperative histopathological examination confirmed the initial diagnosis of malignant mesothelioma. Finally, immunohistochemical examination revealed a localized sarcomatous malignant peritoneal mesothelioma with regional lymph node metastases. The patient was followed up postoperatively as an outpatient, and local recurrence was detected in the abdominal cavity 11 months after surgery. In conclusion, localized malignant peritoneal mesothelioma, especially the sarcomatous type, with large bowel involvement is very rare. We should carefully consider the diagnosis and select adequate therapy, because little is known about the behavior of this disease.
    Rare tumors 07/2010; 2(3). DOI:10.4081/rt.2010.e46
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A Lorentzian model as the general case of a frequency-dependent behavior of a dispersive dielectric material is considered in this paper. Recursive convolution algorithms for the finite-difference time-domain (FDTD) technique for two cases of a Lorentzian medium, narrowband and wideband, depending on the ratio of a resonance line half-width at -3 dB and the resonance frequency of the material, are detailed. It is shown that a wideband Lorentzian model of a dielectric FR-4 used in printed circuit boards is more flexible and gives good agreement with experimental curves, and may be preferable as compared to a Debye model.
    Electromagnetic Compatibility, 2002. EMC 2002. IEEE International Symposium on; 09/2002
  • [Show abstract] [Hide abstract]
    ABSTRACT: Malignant mesothelioma (MM) is a rare primary malignant tumor of the surface serosal cells. The diagnosis of MM is challenging with a broad differential diagnosis. For many decades, studies have focused on distinguishing MM from other types of cancer; however, benign mesothelial cell hyperplasia, especially in small biopsies, has emerged as a major problem. The features of pleural lesions are somewhat different from peritoneal diseases, and this article primarily focuses on pleural diseases. Thorough interpretation and correlation of clinical, radiologic, and pathologic findings are essential for a correct diagnosis.
    Surgical Pathology Clinics 03/2010; 3(1):83-107. DOI:10.1016/j.path.2010.03.010
Show more